Publicacións nas que colabora con Salvador Resino García (23)

2024

  1. IgG antibody levels against the SARS-CoV-2 spike protein in mother–child dyads after COVID-19 vaccination

    Infection, Vol. 52, Núm. 3, pp. 813-824

2023

  1. Antibody levels to SARS-CoV-2 spike protein in mothers and children from delivery to six months later

    Birth, Vol. 50, Núm. 2, pp. 418-427

2011

  1. Adipokine profiles and lipodystrophy in HIV-infected children during the first 4 years on highly active antiretroviral therapy

    HIV Medicine, Vol. 12, Núm. 1, pp. 54-60

2010

  1. Opportunistic infections and organ-specific diseases in HIV-1-infected children: A cohort study (1990-2006)

    HIV Medicine, Vol. 11, Núm. 4, pp. 245-252

2008

  1. Long-term response to highly active antiretroviral therapy with lopinavir/ritonavir in pre-treated vertically HIV-infected children

    Journal of Antimicrobial Chemotherapy, Vol. 61, Núm. 1, pp. 183-190

2007

  1. Long-term response to highly active antiretroviral therapy in human immunodeficiency virus and hepatitis C virus coinfected children: 6 Years of follow-up

    Pediatric Infectious Disease Journal, Vol. 26, Núm. 11, pp. 1061-1064

  2. Slow progression of human immunodeficiency virus and hepatitis C virus disease in a cohort of coinfected children

    Pediatric Infectious Disease Journal, Vol. 26, Núm. 9, pp. 846-849

2006

  1. Antiretroviral activity and safety of lopinavir/ritonavir in protease inhibitor-experienced HIV-infected children with severe-moderate immunodeficiency [4]

    Journal of Antimicrobial Chemotherapy

  2. Effects of highly active antiretroviral therapy with nelfinavir in vertically HIV-1 infected children: 3 years of follow-up. Long-term response to nelfinavir in children

    BMC Infectious Diseases, Vol. 6

  3. La terapia combinada puede ser tan efectiva como la terapia antirretroviral de alta eficacia en el control de la carga viral en niños con un sistema inmunitario conservado

    Acta Pediatrica Espanola, Vol. 64, Núm. 8, pp. 377-382

  4. La terapia combinada puede ser tan efectiva como la terapia antirretroviral de alta eficacia en el control de la carga viral en niños con un sistema inmunitario conservado

    Acta pediátrica española, Vol. 64, Núm. 8, pp. 377

2005

  1. Mutations at codons 54 and 82 of HIV protease predict virological response of HIV-infected children on salvage lopinavir/ritonavir therapy

    Journal of Antimicrobial Chemotherapy, Vol. 56, Núm. 6, pp. 1081-1086

2004

  1. Extensive implementation of highly active antiretroviral therapy shows great effect on survival and surrogate markers in vertically HIV-infected children

    Clinical Infectious Diseases, Vol. 38, Núm. 11, pp. 1605-1612

  2. Salvage lopinavir-ritonavir therapy in human immunodeficiency virus-infected children

    Pediatric Infectious Disease Journal, Vol. 23, Núm. 10, pp. 923-930

  3. Virological phenotype switches under salvage therapy with lopinavir-ritonavir in heavily pretreated HIV-1 vertically infected children

    AIDS, Vol. 18, Núm. 2, pp. 247-255

2003

  1. Characterizing the immune system after long-term undetectable viral load in HIV-1-infected children

    Journal of Clinical Immunology, Vol. 23, Núm. 4, pp. 279-289

  2. Reconstitución clínica e inmunológica completa tras el tratamiento antirretroviral de gran actividad en un niño infectado verticalmente por el virus de la inmunodeficiencia humana tipo 1 con enfermedad avanzada

    Medicina Clinica, Vol. 120, Núm. 11, pp. 417-420

2002

  1. Immunologic recovery after 2-years on HAART in vertically HIV-infected children

    Medicina Clinica, Vol. 118, Núm. 16, pp. 601-604

2001

  1. Estudio de seguimiento nutricional de una población infantil infectada por el VIH

    Acta pediátrica española, Vol. 59, Núm. 10, pp. 563-570

  2. Papel del TNF-α, óxido nítrico y marcadores de progresión en el estado nutricional de niños con infección vertical por VIH-1

    Anales Espanoles de Pediatria, Vol. 54, Núm. 5, pp. 450-457